Corticosteroids in brain cancer patients: benefits and pitfalls
- 1 March 2011
- journal article
- Published by Informa UK Limited in Expert Review of Clinical Pharmacology
- Vol. 4 (2), 233-242
- https://doi.org/10.1586/ecp.11.1
Abstract
Glucocorticoids have been used for decades in the treatment of brain tumor patients and belong to the most powerful class of agents in reducing tumor-associated edema and minimizing side effects and the risk of encephalopathy in patients undergoing radiation therapy. Unfortunately, corticosteroids are associated with numerous and well-characterized adverse effects, constituting a major challenge in patients requiring long-term application of corticosteroids. Novel anti-angiogenic agents, such as bevacizumab (Avastin®), which have been increasingly used in cancer patients, are associated with significant steroid-sparing effects, allowing neuro-oncologists to reduce the overall use of corticosteroids in patients with progressive malignant brain tumors. Recent experimental studies have revealed novel insights into the mechanisms and effects of corticosteroids in cancer patients, including modulation of tumor biology, angiogenesis and steroid-associated neurotoxicity. This article summarizes current concepts of using corticosteroids in brain cancer patients and highlights potential pitfalls in their effects on both tumor and neural progenitor cells.Keywords
This publication has 64 references indexed in Scilit:
- Glucocorticoid use in acute lymphoblastic leukaemiaThe Lancet Oncology, 2010
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- The human glucocorticoid receptor: Molecular basis of biologic functionSteroids, 2009
- End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's CriteriaJournal of Clinical Oncology, 2009
- The use and toxicity of steroids in the management of patients with brain metastasesSupportive Care in Cancer, 2008
- Differential effects of corticosterone and dexamethasone on hippocampal neurogenesis in vitroBiochemical and Biophysical Research Communications, 2004
- The eicosanoid cascade: possible role in gliomas and meningiomasJournal of Clinical Pathology, 2004
- Effect of steroids on iopamidol blood-brain transfer constant and plasma volume in brain tumors measured with X-ray computed tomographyJournal of Neuro-Oncology, 1994
- Steroid-induced remission in primary malignant lymphoma of the central nervous systemSurgical Neurology, 1986
- Antiemetic Efficacy of DexamethasoneNew England Journal of Medicine, 1984